By proceeding, you agree to our Terms of Use and Privacy Policy.
Built with biopharmaceutical industry insights, this in-person meeting will bring together KOLs to delve deep into the key remaining challenges when it comes to identifying, designing and developing the next generation of molecular glues and truly unlock the widespread therapeutic potential of this promising therapy.
Discover mechanisms and biological functions of molecular glues drug development.
Join the summit to review the optimization and mechanism of next-generation glues and unlock the widespread therapeutic potential.
Witness the future directions of the emerging molecular glue degrader field, including known targets, E3s, and non-E3 dependent degraders.
Engage in the molecular toolbox and research to unravel mechanisms and biological functions of molecular glues degrader discovery.
18-19 April 2024
Join us at the MarketsandMarkets High Potent Medicines Conference, taking place on 19th - 20th October 2023, in Boston, USA. This groundbreaking conference is designed to address the emerging trends and challenges in the high potent medicines market.
Event Started
USA
Paid
Boston
Hanson Wade gives people the clarity to see where opportunity lies. We work in highly specialised fields to provide unmatched depth and quality of content. We work in sectors where quality of information is the difference between success and failure.
At Promega Corporation, creativity and connection drive discovery and innovation. We celebrate scientific discovery and the creative application of science to solve problems.
NEOsphere Biotechnologies is a pioneering proteomics company that creates value in strategic partnerships developing small molecule degraders as therapeutic agents against disease targets not yet exploited.
All trademarks, registered trademarks, product names, and company names or logos mentioned in or on this site are the property of their respective owners.
A great community. Legit content. The kind of emails you actually look forward to.